Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

S1P Lyase Regulates Intestinal Stem Cell Quiescence via Ki-67 and FOXO3.

Tytuł:
S1P Lyase Regulates Intestinal Stem Cell Quiescence via Ki-67 and FOXO3.
Autorzy:
Schwiebs A; Institute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt/ZAFES, Hospital of the Goethe University, 60590 Frankfurt am Main, Germany.
Faqar-Uz-Zaman F; Institute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt/ZAFES, Hospital of the Goethe University, 60590 Frankfurt am Main, Germany.
Herrero San Juan M; Institute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt/ZAFES, Hospital of the Goethe University, 60590 Frankfurt am Main, Germany.
Radeke HH; Institute of General Pharmacology and Toxicology, Pharmazentrum Frankfurt/ZAFES, Hospital of the Goethe University, 60590 Frankfurt am Main, Germany.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 May 26; Vol. 22 (11). Date of Electronic Publication: 2021 May 26.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Cellular Senescence*
Aldehyde-Lyases/*metabolism
Forkhead Box Protein O3/*metabolism
Intestinal Mucosa/*metabolism
Ki-67 Antigen/*metabolism
Stem Cells/*metabolism
Aldehyde-Lyases/genetics ; Animals ; Cell Line, Tumor ; Forkhead Box Protein O3/genetics ; Humans ; Ki-67 Antigen/genetics ; Mice ; Mice, Knockout
References:
J Lipid Res. 2020 Jan;61(1):20-32. (PMID: 31690639)
Mediators Inflamm. 2017;2017:5187368. (PMID: 29375197)
Oncotarget. 2016 Feb 2;7(5):6281-93. (PMID: 26823390)
Mol Cancer. 2018 Jul 25;17(1):104. (PMID: 30045773)
Mol Biol Cell. 2017 Jan 1;28(1):21-29. (PMID: 27807046)
Nature. 2000 Apr 13;404(6779):782-7. (PMID: 10783894)
EBioMedicine. 2019 Nov;49:6-8. (PMID: 31648985)
FASEB J. 2009 Feb;23(2):405-14. (PMID: 18824518)
J Mol Neurosci. 2015 May;56(1):177-87. (PMID: 25534920)
Nature. 2000 Nov 23;408(6811):433-9. (PMID: 11100718)
Front Immunol. 2019 Jul 24;10:1698. (PMID: 31396219)
Carcinogenesis. 2010 Oct;31(10):1787-93. (PMID: 20688834)
J Clin Invest. 2014 Dec;124(12):5368-84. (PMID: 25347472)
Int J Mol Sci. 2020 Jun 25;21(12):. (PMID: 32630435)
Prog Lipid Res. 2009 Jan;48(1):62-72. (PMID: 19027789)
Int J Oncol. 2013 Feb;42(2):617-26. (PMID: 23232649)
Trends Cell Biol. 2017 Dec;27(12):906-916. (PMID: 28838621)
Cell Physiol Biochem. 2014;34(1):27-44. (PMID: 24977479)
Cancer Cell. 2013 Jan 14;23(1):107-20. (PMID: 23273921)
J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87. (PMID: 17646672)
Cancer Res. 2017 May 15;77(10):2722-2734. (PMID: 28283655)
Oncogene. 2019 Jun;38(24):4788-4803. (PMID: 30816345)
Biochem J. 2012 Nov 1;447(3):457-64. (PMID: 22908849)
Cell Mol Gastroenterol Hepatol. 2019;7(2):391-408. (PMID: 30718226)
J Clin Med. 2020 May 06;9(5):. (PMID: 32384670)
Front Pharmacol. 2016 Apr 15;7:94. (PMID: 27148053)
Nat Commun. 2020 Oct 28;11(1):5455. (PMID: 33116140)
Dig Dis Sci. 2020 Aug;65(8):2284-2293. (PMID: 31776862)
Nature. 2016 Jun 29;535(7611):308-12. (PMID: 27362226)
Lipids. 2021 Mar;56(2):155-166. (PMID: 32971566)
FASEB J. 2016 Aug;30(8):2945-58. (PMID: 27130484)
Cell. 2013 Oct 10;155(2):369-83. (PMID: 24075009)
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17384-9. (PMID: 17090686)
Oncol Rep. 2015 Oct;34(4):1977-87. (PMID: 26239167)
Grant Information:
SFB1039 Deutsche Forschungsgemeinschaft
Contributed Indexing:
Keywords: AKT signaling; CDK2; FOXO3; Ki-67; S1P lyase; SGPL1 knockout cell line; cell cycle; colon cancer; quiescence
Substance Nomenclature:
0 (FOXO3 protein, human)
0 (Forkhead Box Protein O3)
0 (FoxO3 protein, mouse)
0 (Ki-67 Antigen)
0 (MKI67 protein, human)
0 (Mki67 protein, mouse)
EC 4.1.2.- (Aldehyde-Lyases)
EC 4.1.2.27 (SGPL1 protein, human)
EC 4.1.2.27 (Sgpl1 protein, mouse)
Entry Date(s):
Date Created: 20210602 Date Completed: 20210617 Latest Revision: 20210617
Update Code:
20240104
PubMed Central ID:
PMC8198365
DOI:
10.3390/ijms22115682
PMID:
34073605
Czasopismo naukowe
Background: Reduction of the Sphingosine-1-phosphate (S1P) degrading enzyme S1P lyase 1 (SGPL1) initiates colorectal cancer progression with parallel loss of colon function in mice. We aimed to investigate the effect of SGPL1 knockout on the stem cell niche in these mice.
Methods: We performed immunohistochemical and multi-fluorescence imaging on tissue sections of wildtype and SGPL1 knockout colons under disease conditions. Furthermore, we generated SGPL1 knockout DLD-1 cells (SGPL1 -/-M.Ex1 ) using CRISPR/Cas9 and characterized cell cycle and AKT signaling pathway via Western blot, immunofluorescence, and FACS analysis.
Results: SGPL1 knockout mice were absent of anti-Ki-67 staining in the stem cell niche under disease conditions. This was accompanied by an increase of the negative cell cycle regulator FOXO3 and attenuation of CDK2 activity. SGPL1 -/-M.Ex1 cells show a similar FOXO3 increase but no arrest of proliferation, although we found a suppression of the PDK1/AKT signaling pathway, a prolonged G1-phase, and reduced stem cell markers.
Conclusions: While already established colon cancer cells find escape mechanisms from cell cycle arrest, in vivo SGPL1 knockout in the colon stem cell niche during progression of colorectal cancer can contribute to cell cycle quiescence. Thus, we propose a new function of the S1P lyase 1 in stemness.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies